AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathway
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathway
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started